Frank Sanfilippo

Dr, BSc W.Aust., BPharm GradDipPharm WAIT, PhD W.Aust.

  • The University of Western Australia (M431), 35 Stirling Highway,

    6009 Perth


  • 1580 Citations
  • 22 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Assoc Prof Sanfilippo was awarded a PhD in clinical epidemiology in 2003 from the University of WA (UWA). He is a research-intensive senior academic who was appointed as a cardiovascular research fellow in the School of Population Health UWA in 2005, promoted to senior research fellow in 2012 and promoted to Associate Professor in 2020. He is also a senior pharmacist at Royal Perth Hospital (0.2FTE), starting his clinical career in hospital pharmacy in 1986, including 10 years as a clinical pharmacist. Hence, he has a 34-year clinical work history and a 15-year history as a cardiovascular epidemiologist with expertise in linked data management and analyses, population-based cohort and outcome studies, coronary heart disease, aortic stenosis, heart failure, pharmacoepidemiology, artificial intelligence applications in heart disease, and database development. He has been working with linked data for 25 years since commencing his PhD in 1995, and the majority of his research involves multiple linked datasets from WA and Commonwealth sources.

Since 2005 he has been a chief investigator on 38 grants with competitive funding of $10.5m, of which $6.9m are from 9 NHMRC grants, with a further 8 grants as associate investigator. He has a total of 7 grants as the lead chief investigator (3 from NHMRC, 2 Heart Foundation Vanguard grants, 1 from UWA and 1 from industry). He has 7 grants (4 as lead) in pharmacoepidemiology and medication-related projects in the last 5 years (from NHMRC, WA Department of Health, UWA and industry). He is an author on >120 publications (peer-reviewed papers, letters to editor, reports and 1 book chapter) including in BMJ, Pharmacoepi Drug Safety, BMC Medicine, PLoS One, Heart and Scientific Reports. He has 6 PhD, 7 Master and 1 Honours student completions, and currently has 6 PhD students, 2 groups of medical students and 1 Fellow.

Advice to government: member of the WA Cardiac Outcome Registry Steering Committee advising WA Department of Health. Media: research covered by ABC Radio 720 Perth, SMH newspaper and online newsletters.

Professional memberships: Assoc Prof Sanfilippo is a member of the Society of Hospital Pharmacists of Australia (since 1986), Cardiac Society of Australia and New Zealand (since 2011), Australasian Epidemiological Association (since 2012), International Epidemiological Association (since 2013), American Heart Association/American Stroke Association (since 2017), Pharmaceutical Society of Western Australia (since 2018), Australian Cardiovascular Alliance (since 2019) and WA Cardiovascular Research Alliance (since 2019).

Previous positions

Sep 2001 - Dec 2004: Research Associate, Centre for Health Services Research, School of Population Health, University of Western Australia - working on the project: WA Audit of Surgical Mortality (WAASM).

1 Jan 2005 - 6 May 2005: Project Officer, WA Audit of Surgical Mortality (WAASM), Royal Australasian College of Surgeons (0.4 FTE).

Current projects

1. MOCHAB: Management of coronary heart disease in the Indigenous population in Western Australia: from information to action.

2. WACARP: Evaluation of long-term clinical and health service outcomes following coronary artery revascularisation in Western Australia: future implications.

3. BAHHWA: More Informed Action to Improve Aboriginal Heart Health in Western Australia.

4. green tea: A pilot study of the effect of green tea polyphenols in untreated patients with early stage chronic lymphocytic leukaemia.

5. WAMACH: Long-term use and cost-effectiveness of secondary prevention medications for heart disease in Western Australian seniors.

6. Improving the safety and cost effectiveness of the medication supply process in Western Australian hospitals.

7. AUS-MOCHA: Is the incidence of heart attack still decreasing in Australia? Developing more reliable methods for monitoring trends in myocardial infarction and coronary heart disease.


Cardiovascular disease, Cardiovascular treatment, pharmacoepidemiology, clinical epidemiology, cohort studies, population studies



Research expertise keywords

  • Cardiovascular disease epidemiology and control
  • Clinical epidemiology
  • Pharmacoepidemiology
  • Linked data analysis
  • Cohort studies
  • Population-based studies

Fingerprint Dive into the research topics where Frank Sanfilippo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 34 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Open Access
  • 1 Citation (Scopus)

    Frequent general practitioner visits are protective against statin discontinuation after a Pharmaceutical Benefits Scheme copayment increase

    Seaman, K. L., Sanfilippo, F. M., Bulsara, M. K., Brett, T., Kemp-Casey, A., Roughead, E. E., Bulsara, C. & Preen, D. B., Jun 2020, In : Australian Health Review. 44, 3, p. 377-384 8 p.

    Research output: Contribution to journalArticle

  • Projects

    Press / Media

    Pulmonary rehabilitation study on firmer foot

    Derrick Lopez & Francesco Sanfilippo


    2 items of Media coverage

    Press/Media: Press / Media